In July 2010, the Health Economics Department at Gesundheit Österreich / Austrian Health Institute was designated by the World Health Organization (WHO) a WHO Collaborating Centre (WHO CC) for Pharmaceutical Pricing and Reimbursement Policies.
The designation builds on the expertise which the Pharma Team at the Austrian Health Institute has gained during the last two decades on improving access to affordable medicines. This was mainly achieved through international or European projects and networks, in particular PPRI and PHIS.
With this designation, WHO acknowledges the research and networking done by the Austrian Health Institute in the field of pharmaceutical policies and endorses an expansion of this knowledge for further countries worldwide.
The WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies is the third WHO CC designated in Austria besides the Collaborating Centre for Health & Biomedical Terminology and the Collaborating Centre for Health Promotion in Hospitals & Health Care.
For further information about the concept of WHO Collaborating Centres (e.g. role, functions, management) see http://www.who.int/collaboratingcentres/en/ .